Leukotriene inhibitors drugs

Basic Leukotriene Anti-leukotriene drugs Clinical use of anti-leukotriene therapy inhibitors and cysteinyl LT receptor antagonists

Leukotriene modifiers, also called leukotriene receptor antagonists or leukotriene synthesis inhibitors, are medications that block the effect of leukotrienes or stop your body from producing them. These drugs are used to prevent or lessen the symptoms of:

What are leukotriene modifiers and what do they treat? Leukotriene modifiers, also called leukotriene receptor antagonists or leukotriene synthesis inhibitors, are medications that block the effect of leukotrienes or stop your body from producing them. These drugs are used to prevent or lessen the symptoms of: Allergies (allergic rhinitis).

Drugs that modify the production or activity of leukotriene are known as leukotriene inhibitors, leukotriene receptor antagonists, or leukotriene modifiers. Some of these drugs work by limiting

Leukotriene-Inhibiting Drugs. Leukotriene inhibitors are either leukotriene receptor antagonists or leukotriene synthesis inhibitors, which act by blocking 5-lipoxygenase activity.

Leukotriene modifiers include LTRAs and leukotriene inhibitors, which both act as anti-inflammatory medications. LTRAs block leukotriene receptors, whereas leukotriene inhibitors block the

Leukotriene-receptor antagonists, such as montelukast and zafirlukast, prevent leukotrienes from binding to their receptors. Leukotriene synthesis inhibitors

Particularly important in asthma, leukotriene receptors on the airways mediate a potent bronchoconstriction. Two general types of drugs have been developed with the goal of attenuating the leukotrienes' effects in inflammation and asthma: the leukotriene receptor blockers and the leukotriene synthesis inhibitors (eg, 5-lipoxygenase inhibitors).

Notes ; DRUG NAME, montelukast (Singulair), zafirlukast (Accolate), zileuton ; CLASS, Leukotriene receptor antagonists, Leukotriene synthesis inhibitor ; MECHANISM